ShigaShield - Intralytix
Alternative Names: ShigActive™; ShigaShield™Latest Information Update: 11 Oct 2023
At a glance
- Originator Intralytix
- Class Antibacterials; Bacteriophages
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I/II Shigella infections